Log In
Print
BCIQ
Print
Print this Print this
 

Gazyva, obinutuzumab (GA101, RG7159, RO5072759)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionGlycoengineered humanized mAb against CD20
Molecular Target CD20
Mechanism of ActionBinds CD20; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today